Cerebellum’s Fifth Third Bancorp FITB Stock Holding History

Cerebellum’s Portfolio FITB Stock Details FITB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$568K	Buy	18,472 +1,968	+12%	+$57.7K	0.3%	41
2019 Q3	$452K	Buy	16,504 +3,727	+29%	+$102K	0.29%	71
2019 Q2	$356K	Buy	12,777 +9,814	+331%	+$269K	0.29%	81
2019 Q1	$75K	Buy	+2,963	New	+$78.9K	0.07%	374

Other funds holding FITB

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Cerebellum's FITB Position: Q4 2019 in Review

Cerebellum increased its Fifth Third Bancorp (FITB) stake by 12% in Q4 2019, buying an estimated $57.7K and bringing the position to 18,472 shares worth $568K. The position accounts for 0.3% of the portfolio, ranked #41.

Cerebellum first reported a position in FITB in Q1 2019 and has held it in 4 quarters since. 780 funds tracked by Wall St. Rank hold FITB as of Q4 2019.

Cerebellum held 18,472 shares of Fifth Third Bancorp worth $568K as of Q4 2019.
Cerebellum bought 1,968 Fifth Third Bancorp shares in Q4 2019, an estimated $57.7K.
Fifth Third Bancorp made up 0.3% of Cerebellum's portfolio in Q4 2019, its #41 holding.
Cerebellum first reported a position in Fifth Third Bancorp in Q1 2019 and has held it in 4 quarters since.
780 funds tracked by Wall St. Rank held Fifth Third Bancorp as of Q4 2019.

Based on Cerebellum's 13F filing for Q4 2019, filed 16 Jan 2020.